Picture of Celyad Oncology SA logo

CYAD — Celyad Oncology SA News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Celyad Announces Pricing of $20.0 Million Global Offering

Sept 12 (Reuters) - CELYAD SA  CYAD.BR :
    * CELYAD ANNOUNCES PRICING OF $20.0 MILLION GLOBAL OFFERING
    * PRICING OF GLOBAL OFFERING OF 2,000,000 ORDINARY SHARES,
COMPRISED OF 1,717,391 ORDINARY SHARES IN FORM OF AMERICAN
DEPOSITARY SHARES (“ADSS”) OFFERED IN UNITED STATES, CANADA AND
CERTAIN COUNTRIES OUTSIDE OF EUROPE
    * GROSS PROCEEDS TO CELYAD FROM THE GLOBAL OFFERING ARE
EXPECTED
TO BE APPROXIMATELY $20.0 MILLION
    * THE CLOSING OF THE GLOBAL OFFERING IS EXPECTED TO OCCUR ON
SEPTEMBER 16, 2019, AND IS SUBJECT TO CUSTOMARY CLOSING
CONDITIONS.
    * PRICE PER ADS OF $10.00 (THE “U.S. OFFERING”), AND 282,609
ORDINARY SHARES IN EUROPE AND CERTAIN COUNTRIES OUTSIDE OF
UNITED STATES AND CANADA IN CONCURRENT PRIVATE PLACEMENT AT
PRICE PER SHARE OF €9.08
    * IN CONNECTION WITH GLOBAL OFFERING, CELYAD HAS GRANTED
UNDERWRITERS A 30-DAY OPTION TO PURCHASE UP TO AN ADDITIONAL
300,000 ORDINARY SHARES (WHICH MAY BE IN THE FORM OF ADSS) ON
SAME TERMS AND CONDITIONS

Source text for Eikon:  ID:nGNX2RfldG 
Further company coverage:  CYAD.BR 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Celyad Oncology SA

See all news